IRONWOOD PHARMACEUTICALS INC's ticker is and the CUSIP is 46333XAH1. A total of 22 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,258,839 | -55.8% | 1,250,000 | -51.9% | 0.04% | -46.6% |
| Q4 2022 | $2,848,625 | -31.9% | 2,600,000 | -36.6% | 0.07% | -20.7% |
| Q3 2022 | $4,185,000 | -52.6% | 4,100,000 | -49.4% | 0.09% | -53.8% |
| Q2 2022 | $8,829,000 | -8.3% | 8,100,000 | 0.0% | 0.20% | -20.7% |
| Q1 2022 | $9,627,000 | +3.8% | 8,100,000 | 0.0% | 0.25% | +5.9% |
| Q4 2021 | $9,275,000 | -5.2% | 8,100,000 | 0.0% | 0.24% | -15.4% |
| Q3 2021 | $9,780,000 | -39.6% | 8,100,000 | -40.0% | 0.28% | -38.5% |
| Q2 2021 | $16,193,000 | +24.2% | 13,500,000 | +17.4% | 0.46% | -3.0% |
| Q1 2021 | $13,038,000 | +54.4% | 11,500,000 | +53.3% | 0.47% | +58.4% |
| Q4 2020 | $8,444,000 | +57.5% | 7,500,000 | +36.4% | 0.30% | +52.6% |
| Q3 2020 | $5,360,000 | – | 5,500,000 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAMDEN ASSET MANAGEMENT L P /CA | 35,225,000 | $39,760,000 | 1.94% |
| SHENKMAN CAPITAL MANAGEMENT INC | 4,079,000 | $4,662,000 | 0.54% |
| AQR Arbitrage LLC | 11,500,000 | $13,038,000 | 0.47% |
| Context Capital Management, LLC | 3,934 | $4,460,000 | 0.44% |
| Polar Asset Management Partners Inc. | 7,000,000 | $7,938,000 | 0.08% |
| Calamos Advisors LLC | 9,500,000 | $10,748,000 | 0.06% |
| LINDEN ADVISORS LP | 6,201,000 | $7,007,000 | 0.05% |
| LAZARD ASSET MANAGEMENT LLC | 14,500,000 | $16,439,000 | 0.02% |
| Citadel Advisors | 68,788,000 | $77,681,000 | 0.02% |
| PUTNAM INVESTMENTS LLC | 7,976,000 | $9,002,000 | 0.02% |